Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904)

Currency in USD
0.434
-0.008(-1.81%)
Closed·
900904 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4340.441
52 wk Range
0.4030.538
Key Statistics
Bid/Ask
0.434 / 0.435
Prev. Close
0.434
Open
0.441
Day's Range
0.434-0.441
52 wk Range
0.403-0.538
Volume
155.2K
Average Volume (3m)
314.79K
1-Year Change
-18.4211%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
900904 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 28, 2026
EPS / Forecast
0.02 / --
Revenue / Forecast
425.19M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.05%
Dividend Yield
2.32%
Industry Median 1.75%
Annualised payout
0.01
Paid annually
5-Years Growth
-
Growth Streak

900904 Income Statement

Compare 900904 to Peers and Sector

Metrics to compare
900904
Peers
Sector
Relationship
P/E Ratio
150.1x21.7x−0.4x
PEG Ratio
−2.570.080.00
Price/Book
1.8x2.4x2.6x
Price / LTM Sales
2.2x3.5x3.0x
Upside (Analyst Target)
-39.1%58.0%
Fair Value Upside
Unlock16.7%7.8%Unlock

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides toothache relief drops; parsnicillin tablets, compound amino acid vitamin capsules, compound chlorhexidine dexamethasone, nasal and mouth cleansing spray, constipation relief capsules, anwei tablets, motherwort paste, gynecological menstrual regulating tablets, Sangju cold tablets, hawthorn granules, isatis root granules, col and cough syrup, and gastritis relief granules, as well as acetaminophen, caffeine, and flavoxate tablets. The companys products are used for therapeutic areas such as anti-tumor, cold and cough relief, cardiovascular and cerebrovascular diseases, rheumatic bone pain, antifungal, tonifying and calming mind, and gynecological diseases. In addition, it is involved in wholesale and retail trade, and culture and art businesses; provision of software and information technology services. It also exports its products. The company was founded in 1992 and is based in Shanghai, China.

Employees
1196
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.76M1.08%2.50M
Other Institutional Investors
228.29M42.75%99.08M
Public Companies & Retail Investors
300.02M56.18%130.21M
Total
534.07M100.00%231.79M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guizhou Shenqi Investment Co., Ltd.16.98%90,661,62039,347
Guizhou Maijisi Investment Management Co., Ltd.16.48%88,001,94638,193

FAQ

What Is the Shanghai Shenqi Pharm B (900904) Stock Price Today?

The Shanghai Shenqi Pharm B stock price today is 0.434 USD.

What Stock Exchange Does Shanghai Shenqi Pharm B Trade On?

Shanghai Shenqi Pharm B is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Shanghai Shenqi Pharm B?

The stock symbol for Shanghai Shenqi Pharm B is "900904."

What Is the Shanghai Shenqi Pharm B Market Cap?

As of today, Shanghai Shenqi Pharm B market cap is 612.970M USD.

What Is Shanghai Shenqi Pharm B's Earnings Per Share (TTM)?

The Shanghai Shenqi Pharm B EPS (TTM) is 0.050.

From a Technical Analysis Perspective, Is 900904 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Shanghai Shenqi Pharm B Stock Split?

Shanghai Shenqi Pharm B has split 5 times.

How Many Employees Does Shanghai Shenqi Pharm B Have?

Shanghai Shenqi Pharm B has 1196 employees.

What is the current trading status of Shanghai Shenqi Pharm B (900904)?

As of Sep 27, 2026, Shanghai Shenqi Pharm B (900904) is trading at a price of 0.434 USD, with a previous close of 0.434 USD. The stock has fluctuated within a day range of 0.434 USD to 0.441 USD, while its 52-week range spans from 0.403 USD to 0.538 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.